CRTh2 receptor antagonists

Details for Australian Patent Application No. 2005238199 (hide)

Owner Novartis AG

Inventors Leblanc, Catherine; Turner, Katharine Louise; Sandham, David Andrew

Agent Davies Collison Cave

Pub. Number AU-B-2005238199

PCT Pub. Number WO2005/105727

Priority 0409921.4 04.05.04 GB

Filing date 3 May 2005

Wipo publication date 10 November 2005

Acceptance publication date 26 March 2009

International Classifications

C07C 255/54 (2006.01) Carboxylic acid nitriles

C07C 51/09 (2006.01) Preparation of carboxylic acids or their salts, halides, or anhydrides - from carboxylic acid esters or lactones

C07C 59/72 (2006.01) Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O-metal, CHO, keto, ether, groups, groups, or groups

C07C 67/11 (2006.01) Preparation of carboxylic acid esters

C07C 69/712 (2006.01) Esters of carboxylic acids

Event Publications

9 November 2006 PCT application entered the National Phase

  PCT publication WO2005/105727 Priority application(s): WO2005/105727

26 March 2009 Application Accepted

  Published as AU-B-2005238199

23 July 2009 Standard Patent Sealed

2 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005238202-Neural cell differentiation method from ES cells

2005238195-Process for the production of cyclic diketones